4//SEC Filing
PRESTRELSKI STEVEN 4
Accession 0001867096-22-000006
CIK 0001867096other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:15 PM ET
Size
7.9 KB
Accession
0001867096-22-000006
Insider Transaction Report
Form 4
PRESTRELSKI STEVEN
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-01-03+75,000→ 569,780 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001744027
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:15 PM ET
- Size
- 7.9 KB